Browsing Pharmaceutical Sciences by Author "Elnour, Asim Ahmed"
Now showing items 1-3 of 3
-
The flavonoid luteolin reduces mutant huntingtin aggregation and cytotoxicity in huntingtin-mutated neuroblastoma cells
Ramadan, Azza; Mohammed, Abuelnor; Elnour, Asim Ahmed; Sadeq, Adel; Al Mazrouei, Nadia; Alkaabi, Maisoun; Al-Kubaisi, Khalid Awad; Beshir, Semira Abdi; Menon, Vineetha; AlAmoodi, Abdulla; Sam, Kishore Ganana; Saeed, Ali Awadallah Ali Mohamed; Abdalla, Sami Fatehi; Hussein, Samah Mohammed (Elsevier B.V., 2023-12)Background: Huntington's disease is an inherited progressive neurodegenerative disorder caused by an expansion of the polyglutamine tract leading to malformation and aggregation of the mutant huntingtin protein in the cell ... -
Protocol for systematic review and meta-analysis of randomized controlled trials, cost-benefit analysis and interrupted time-series interventions on pharmacist’s prescribing
Elnour, Asim Ahmed; Raja, Nadia Sarfaraz; Abdi, Fatemeh; Mostafiz, Fariha; Elmubarak, Razan Isam; Khalil, Alaa Mohsen; Hait, Khawla Abou; Alqahtani, Mariam Mohamed; Dabbagh, Nour; Abdulnasser, Zainab; Albek, Danah; Amer, Abdelfattah; Al Damook, Nosayba Othman; Shayeb, Aya; Alblooshi, Sara; Samir, Mohammed; Hajal, Abdallah Abou; Al Barakani, Nora; Balbahaith, Rahf; Al Mazrouie, Hamda; Ali, Rahaf Ahmed (Grupo de Investigacion en Atencion Farmaceutica, 2022)Background: Shortening the process of prescribing via permitting the pharmacist to select the most appropriate pharmaceuticals for each particular patient may provide great opportunities for pharmacists to develop suitable ... -
The usage pattern of patients’ drug information leaflet for oral non-prescription drugs among university students in the United Arab Emirates: cross-sectional study
Al-Kubaisi, Khalid A.; Abduelkarem, Abduelmula R.; Elnour, Asim Ahmed; El Khidir, Israa Yousif; Hassanein, Mohamed M. (Grupo de Investigacion en Atencion Farmaceutica, 2023)Background: Very few extensive studies have measured the prevalence and usage pattern of drug information leaflet (DIL) for oral non-prescription drugs (ONPDs) or identified the associated risk factors for not reading DIL ...